Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Gross Margin (2020 - 2026)

Clene (CLNN) posted Gross Margin of 60.0% for Q2 2026, down 14.44% on a QoQ basis from 70.13% in Q4 2025, and down 4000.0% year-over-year from 1.54% in Q2 2025.

Analysis

Clene (CLNN) Gross Margin (2020 - 2026) Analysis & Trends

Clene has reported Gross Margin for 7 years, with the latest figure at 60.0% in Q2 2026.

  • On a quarterly basis, Gross Margin fell 4000.0% year-over-year to 60.0% in Q2 2026; TTM through Jun 2026 was 71.77%, a 865.0% decrease from a year earlier, with the FY2025 full-year figure at 78.5%, down 103.0% from the prior year.
  • Gross Margin was 60.0% for Q2 2026 at Clene, down from 70.13% in the prior quarter.
  • The five-year high for Gross Margin was 100.0% in Q1 2022, with the low at 60.0% in Q2 2026.
  • Average Gross Margin over 5 years is 85.1%, with a median of 80.22% recorded in 2024.
  • The largest YoY upside for Gross Margin was 27612 bps in 2022 against a maximum downside of 26581 bps in 2022.
  • Over 5 years, Gross Margin stood at 97.01% in 2022, then fell by 20 bps to 77.65% in 2023, then advanced by 3 bps to 80.22% in 2024, then fell by 13 bps to 70.13% in 2025, then fell by 14 bps to 60.0% in 2026.
  • The last three Gross Margin figures came in at 60.0% (Q2 2026), 70.13% (Q4 2025), and 100.0% (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 68.19%
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 74.74%
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 73.54%
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 78.02%
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 72.78%
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 80.05%
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 93.73%
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 87.30%
10 Clene 45.69 Mn 45.69 Mn 54,000.00 60.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.00%
Dec 31, 2025 70.13%
Sep 30, 2025 100.00%
Jun 30, 2025 100.00%
Mar 31, 2025 75.31%
Dec 31, 2024 80.22%
Sep 30, 2024 79.31%
Jun 30, 2024 80.22%
Mar 31, 2024 78.08%
Dec 31, 2023 77.65%
Sep 30, 2023 88.89%
Jun 30, 2023 75.46%
Mar 31, 2023 95.33%
Dec 31, 2022 97.01%
Sep 30, 2022 89.08%
Jun 30, 2022 100.00%
Mar 31, 2022 100.00%
Dec 31, 2021 362.81%
Sep 30, 2021 87.27%
Jun 30, 2021 -176.12%